Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. (TSHA) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
tsha · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, Taysha Gene Therapies, Inc. (TSHA) has a market cap — also referred to as its net worth or valuation — of $1.4B, making it one of the top most valuable companies globally. Market Cap = $5.43 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Taysha Gene Therapies, Inc. (TSHA) has a market cap — also referred to as its net worth or valuation — of $1.4B as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Taysha Gene Therapies, Inc. reached its all-time high market cap of $7.4B on Jun 24, 2021. Comparing the Taysha Gene Therapies, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Taysha Gene Therapies, Inc. net worth vs peers and ask how Taysha Gene Therapies, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
TSHA market cap · 6 questionsTaysha Gene Therapies, Inc.'s net worth — measured as market capitalization — is $1.4B as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$5.43 (price) × shares outstanding.